The microbiome and prostate cancer
- PMID: 34267333
- PMCID: PMC8767983
- DOI: 10.1038/s41391-021-00413-5
The microbiome and prostate cancer
Abstract
There is growing evidence that the microbiome is involved in development and treatment of many human diseases, including prostate cancer. There are several potential pathways for microbiome-based mechanisms for the development of prostate cancer: direct impacts of microbes or microbial products in the prostate or the urine, and indirect impacts from microbes or microbial products in the gastrointestinal tract. Unique microbial signatures have been identified within the stool, oral cavity, tissue, urine, and blood of prostate cancer patients, but studies vary in their findings. Recent studies describe potential diagnostic and therapeutic applications of the microbiome, but further clinical investigation is needed. In this review, we explore the existing literature on the discovery of the human microbiome and its relationship to prostate cancer.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Juan Javier-DesLoges, MD, MS – No Conflict of Interest
Rana R. McKay, MD- No Conflict of Interest
Austin D. Swafford, PhD. - No Conflict of Interest
Gregory D. Sepich-Poore, B.S.E. - No Conflict of Interest
Rob Knight, PhD. - No Conflict of Interest
J. Kellogg Parsons MD, MHS - No Conflict of Interest
References
-
- Wheeler KM, Liss MA. The Microbiome and Prostate Cancer Risk. Curr Urol Rep 2019; 20: 66. - PubMed